We further investigated co-expression of LAP and GARP on FoxP3+/–Helios+/– T cell subsets in HD, PC and LICRC patients in non-activated (Figure 5) and activated settings (Figure 6). This evidence concerns the gene TGFB1 and Huntington disease.